Seven Fleet Capital Management’s Cidara Therapeutics CDTX Stock Holding History

Seven Fleet Capital Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,026	Closed	-$668K	–	120
2025 Q4	$668K	Buy	+3,026	New	+$489K	0.45%	40

Seven Fleet Capital Management's CDTX Position: Q1 2026 in Review

Seven Fleet Capital Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 3,026 shares — an estimated $668K sold.

Seven Fleet Capital Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $668K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Seven Fleet Capital Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Seven Fleet Capital Management sold 3,026 Cidara Therapeutics shares in Q1 2026, an estimated $668K.
Seven Fleet Capital Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Seven Fleet Capital Management's Cidara Therapeutics position peaked at $668K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.